75 related articles for article (PubMed ID: 17693286)
1. Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
Kaifi JT; Rawnaq T; Schurr PG; Yekebas EF; Mann O; Merkert P; Link BC; Kalinin V; Pantel K; Sauter G; Strate T; Izbicki JR
Am J Surg; 2007 Sep; 194(3):380-4. PubMed ID: 17693286
[TBL] [Abstract][Full Text] [Related]
2. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
Blessmann M; Kaifi JT; Schurr PG; Cihan A; Kalinin V; Trump F; Atac A; Heiland M; Pohlenz P; Blake F; Schmelzle R; Izbicki JR
Oral Oncol; 2008 Feb; 44(2):143-7. PubMed ID: 17418617
[TBL] [Abstract][Full Text] [Related]
3. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
Kaifi JT; Cataldegirmen G; Wachowiak R; Schurr PG; Kleinhans H; Kosti G; Yekebas EF; Mann O; Kutup A; Kalinin V; Strate T; Izbicki JR
Anticancer Res; 2007; 27(1A):69-73. PubMed ID: 17352218
[TBL] [Abstract][Full Text] [Related]
4. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.
Yue CM; Bi MX; Tan W; Deng DJ; Zhang XY; Guo LP; Lin DX; Lu SH
Int J Cancer; 2004 Jan; 108(2):232-6. PubMed ID: 14639608
[TBL] [Abstract][Full Text] [Related]
5. Relationship between esophageal cancer-related gene 2 polymorphism and esophageal squamous cell carcinomas in Kazakhs and Hans of Xinjiang.
Gao L; Li J; Zheng Y
Int J Clin Exp Pathol; 2019; 12(9):3408-3416. PubMed ID: 31934184
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
10. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
11. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
[TBL] [Abstract][Full Text] [Related]
12. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
13. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study.
Hirasaki S; Noguchi T; Mimori K; Onuki J; Morita K; Inoue H; Sugihara K; Mori M; Hirano T
Oncologist; 2007 Apr; 12(4):406-17. PubMed ID: 17470683
[TBL] [Abstract][Full Text] [Related]
14. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
15. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G
Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations in Barrett's epithelium and esophageal cancer.
Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
Cancer Res; 1991 Aug; 51(16):4495-9. PubMed ID: 1868473
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China.
Guo W; Wang N; Li Y; Zhang JH
Chin Med J (Engl); 2005 Nov; 118(22):1870-8. PubMed ID: 16313841
[TBL] [Abstract][Full Text] [Related]
19. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
Joshi MB; Shirota Y; Danenberg KD; Conlon DH; Salonga DS; Herndon JE; Danenberg PV; Harpole DH
Clin Cancer Res; 2005 Mar; 11(6):2215-21. PubMed ID: 15788669
[TBL] [Abstract][Full Text] [Related]
20. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
